Susan van der Lei
Papers
1
Total Citations
47
H-Index
1
About
Dr. Susan van der Lei is a leading surgical oncologist whose work is redefining the standard of care for patients with colorectal liver metastases (CRLM). Her primary research focuses on the comparative effectiveness and safety of surgical resection versus thermal ablation for small-size liver tumors. Dr. van der Lei’s most notable contribution is her role as a principal investigator in the landmark COLLISION trial, an international, multicenter, phase III randomized controlled trial (2024, 47 citations). This pivotal study directly challenged the long-held dogma that surgery is the only gold-standard local treatment, demonstrating that thermal ablation offers a superior safety profile, lower costs, and shorter hospital stays while rivaling the oncologic outcomes of resection for small CRLM. Her work has provided high-level evidence that is now reshaping clinical guidelines and treatment algorithms worldwide. By rigorously comparing these two modalities, Dr. van der Lei has empowered multidisciplinary teams to offer patients a less invasive, equally effective option, significantly improving quality of life and healthcare efficiency. Her contributions are instrumental in moving the field toward personalized, evidence-based local therapy for metastatic colorectal cancer.
Research Focus
Key Achievements
Top Papers
- 1